Bumper Offer - Urjas oil Just @ Rs. 1
Recita is a prescription medicine that is available as a Tablet, Injection. Primarily, it is used for the treatment of Depression. Secondary and off-label uses of Recita have also been mentioned below.
The correct dosage of Recita depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Recita as well, which are listed below. These side effects of Recita are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Recita is Moderate for pregnant women and Severe for women who are breastfeeding. It is important to know if Recita has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Recita related warnings section.
Some other conditions that can be affected by Recita are listed in the contraindications section below.
Drug reaction of Recita with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Recita is not safe while driving, and is not addiction.
Recita is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Adult(Male) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Recita is used -
Moderate
Mild
Is the use of Recita safe for pregnant women?
Recita may have some side effects during pregnancy. Pregnant women should discontinue the use of Recita, and talk to their doctor, if they notice any discomfort.
Is the use of Recita safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Recita. It should only be taken after medical advice.
What is the effect of Recita on the Kidneys?
Recita has very mild side effects on the kidneys.
What is the effect of Recita on the Liver?
Recita is rarely harmful for the liver.
What is the effect of Recita on the Heart?
Recita is rarely harmful for the heart.
Recita should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Recita unless your doctor advises you to do so -
Is this Recita habit forming or addictive?
Recita is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Recita you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Recita should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, this Recita works for mental disorders.
Interaction between Food and Recita
Taking Recita with food does not harm your health.
Interaction between Alcohol and Recita
Taking Recita with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lexapro® (escitalopram oxalate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 461
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 520-522